Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Interest Income Over TimeContracting
Percentile Rank79
3Y CAGR+16.9%
5Y CAGR+5.0%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+16.9%/yr
Annual compound
5Y CAGR
+5.0%/yr
Recent acceleration
Percentile
P79
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.32M | -22.7% |
| 2024 | $1.72M | +5.3% |
| 2023 | $1.63M | +96.5% |
| 2022 | $829000.00 | +41350.0% |
| 2021 | $2000.00 | -99.8% |
| 2020 | $1.04M | -38.3% |
| 2019 | $1.69M | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |